Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 23: WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR
Author(s): Samir R Kapadia Added: 1 year ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more

Electrophysiology & Arrhythmia

Intervention
Transcatheter LAA Closure
Author(s): Chirag Bavishi Added: 1 year ago

Vascular Disease and Surgery

Electrophysiology & Arrhythmia
Transseptal Access After Interatrial Shunt Devices: Try Everything Once and Great Things Twice
Author(s): Molly Silkowski , Nicholas Amoroso Added: 1 year ago

Heart Failure

Electrophysiology & Arrhythmia
AHA 24: The OPTION Trial
Author(s): Oussama M Wazni Added: 4 months ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more

Anticoagulation

Electrophysiology & Arrhythmia
AHA 24: The Amulet IDE Trial
Author(s): Dhanunjaya Lakkireddy Added: 5 months ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE … View more

Electrophysiology & Arrhythmia
Pugazhendhi Vijayaraman
Research Area(s) / Expertise:
Dr Pugazhendhi Vijayaraman obtained his medical degree from Madurai Medical College and completed his residency at Jacobi Medical Center. He completed his fellowships in cardiovascular diseases and clinical cardiac electrophysiology at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center. Dr Vijayaraman specialises in cardiac electrophysiology, cardiac… View more
Research Area(s) / Expertise: Job title: Cardiologist
Dr Robert Cubeddu is President at NCH Rooney Heart Institute, Florida, US and is board-certified in Cardiovascular Medicine and Interventional Cardiology, with advanced sub-specialty training in Structural Heart Disease.Dr Cubeddu founded a comprehensive, high-volume premier regional centre of referral in Structural Heart including percutaneous transcatheter valves therapies (TAVR, TMVR,… View more
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 1 year ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more

Intervention